Tekla Capital Management as of March 31, 2013
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 61 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 10.5 | $74M | 1.5M | 48.93 | |
| Celgene Corporation | 8.4 | $59M | 510k | 115.91 | |
| Regeneron Pharmaceuticals (REGN) | 7.0 | $49M | 280k | 176.40 | |
| Biogen Idec (BIIB) | 6.0 | $42M | 219k | 192.91 | |
| Alexion Pharmaceuticals | 4.9 | $34M | 371k | 92.14 | |
| Puma Biotechnology (PBYI) | 4.8 | $34M | 1.0M | 33.39 | |
| Perrigo Company | 3.4 | $24M | 203k | 118.73 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $21M | 380k | 54.98 | |
| Onyx Pharmaceuticals | 3.0 | $21M | 235k | 88.86 | |
| Mylan | 2.7 | $19M | 651k | 28.94 | |
| Hologic (HOLX) | 2.6 | $18M | 813k | 22.60 | |
| Merck & Co (MRK) | 1.9 | $13M | 297k | 44.23 | |
| Akorn | 1.9 | $13M | 936k | 13.83 | |
| Cubist Pharmaceuticals | 1.8 | $13M | 266k | 46.82 | |
| Teva Pharmaceutical Industries (TEVA) | 1.8 | $12M | 312k | 39.68 | |
| Shire | 1.7 | $12M | 127k | 91.36 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $12M | 944k | 12.14 | |
| Questcor Pharmaceuticals | 1.6 | $11M | 348k | 32.54 | |
| Ariad Pharmaceuticals | 1.6 | $11M | 619k | 18.09 | |
| Warner Chilcott Plc - | 1.5 | $11M | 783k | 13.55 | |
| Aetna | 1.4 | $10M | 197k | 51.12 | |
| Incyte Corporation (INCY) | 1.4 | $9.9M | 421k | 23.41 | |
| Medivation | 1.4 | $9.9M | 211k | 46.77 | |
| Endo Pharmaceuticals | 1.4 | $9.8M | 318k | 30.76 | |
| Amgen (AMGN) | 1.4 | $9.7M | 95k | 102.51 | |
| Alere | 1.3 | $9.0M | 352k | 25.53 | |
| Verastem | 1.2 | $8.5M | 885k | 9.62 | |
| Actavis | 1.2 | $8.4M | 92k | 92.11 | |
| Amarin Corporation (AMRN) | 1.1 | $7.9M | 1.1M | 7.41 | |
| Nektar Therapeutics (NKTR) | 1.1 | $7.4M | 675k | 11.00 | |
| Alkermes (ALKS) | 1.1 | $7.4M | 313k | 23.71 | |
| Allergan | 0.9 | $6.6M | 59k | 111.64 | |
| ImmunoGen | 0.9 | $6.3M | 394k | 16.06 | |
| Illumina (ILMN) | 0.9 | $6.2M | 115k | 54.00 | |
| McKesson Corporation (MCK) | 0.9 | $6.1M | 57k | 107.96 | |
| Baxter International (BAX) | 0.8 | $5.6M | 78k | 72.64 | |
| Forest Laboratories | 0.8 | $5.6M | 147k | 38.04 | |
| Impax Laboratories | 0.8 | $5.3M | 345k | 15.44 | |
| IDEXX Laboratories (IDXX) | 0.7 | $5.2M | 56k | 92.38 | |
| UnitedHealth (UNH) | 0.7 | $4.7M | 82k | 57.21 | |
| Acorda Therapeutics | 0.7 | $4.6M | 145k | 32.03 | |
| United Therapeutics Corporation (UTHR) | 0.6 | $4.5M | 73k | 60.87 | |
| CVS Caremark Corporation (CVS) | 0.6 | $3.9M | 72k | 54.99 | |
| Ironwood Pharmaceuticals (IRWD) | 0.5 | $3.8M | 208k | 18.29 | |
| Edwards Lifesciences (EW) | 0.5 | $3.6M | 44k | 82.15 | |
| Accuray Incorporated (ARAY) | 0.5 | $3.4M | 732k | 4.64 | |
| Curis | 0.5 | $3.2M | 989k | 3.28 | |
| Intellipharmaceuticsintl Inc C | 0.5 | $3.2M | 1.7M | 1.82 | |
| Vivus | 0.4 | $2.9M | 262k | 11.00 | |
| Covance | 0.4 | $2.6M | 35k | 74.31 | |
| Sagent Pharmaceuticals | 0.3 | $2.5M | 141k | 17.55 | |
| Dendreon Corporation | 0.2 | $1.8M | 377k | 4.73 | |
| Celldex Therapeutics | 0.2 | $1.6M | 140k | 11.58 | |
| Ceres | 0.2 | $1.5M | 427k | 3.48 | |
| OncoGenex Pharmaceuticals | 0.2 | $1.3M | 113k | 11.33 | |
| Synta Pharmaceuticals | 0.2 | $1.1M | 129k | 8.60 | |
| Merrimack Pharmaceuticals In | 0.2 | $1.1M | 184k | 6.10 | |
| Endocyte | 0.1 | $749k | 60k | 12.44 | |
| Cornerstone Therapeutics | 0.1 | $467k | 66k | 7.06 | |
| Icad (ICAD) | 0.1 | $442k | 89k | 4.99 | |
| Sanofi Aventis Wi Conval Rt | 0.0 | $185k | 104k | 1.78 |
